Lobbying Filing Details

Total Spending

$870,000

Activities

5

Lobbyists

5

Gov't Entities

20

Filing Information
Filing UUID:
798331d9-24f5-4ffb-87dc-130f6eb57034
Type:
Q3 - 3rd Quarter - Report
Period:
2015 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 20, 2015 at 11:27 PM
Income:
$0
Expenses:
$870,000
Expense Method:
Method C - Reporting amounts under section 162(e) of the Internal Revenue Code
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Christian Cruz
Registrant
ASSOCIATION FOR ACCESSIBLE MEDICINES

Association representing the interests of the generic pharmaceutical industry.

Washington, District of Columbia
Client
ASSOCIATION FOR ACCESSIBLE MEDICINES
District of Columbia, United States of America
Lobbying Activities (5)
Activity 1
Budget/Appropriations

FDA Funding, H.R. 1078 FDA Safety Over Sequestration Act, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2016, Administration budget for Fiscal Year 2017

Lobbyists (3)
  • MR. CHRISTOPHER DAVIS
  • MELISSA SCHULMAN
  • HEIDI WILSON
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Commerce, Dept of (DOC)
  • Health & Human Services, Dept of (HHS)
Activity 2
Copyright/Patent/Trademark

H.R. 9 The Innovation Act, S. 1137 PATENT Act, S. 2019 Preserve Access to Affordable Generics Act

Lobbyists (4)
  • MR. CHRISTOPHER DAVIS
  • MELISSA SCHULMAN
  • HEIDI WILSON
  • CHRISTIAN OMAR CRUZ
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Commerce, Dept of (DOC)
  • Health & Human Services, Dept of (HHS)
Activity 3
Medicare/Medicaid

Medicare Part D Program and Generic Drugs,H.R. 2391 Medicaid Generic Drug Price Fairness Act, S. 1364 Medicaid Generic Drug Price Fairness Act, Medicare reimbursement for biosimilars

Lobbyists (4)
  • MR. CHRISTOPHER DAVIS
  • MELISSA SCHULMAN
  • HEIDI WILSON
  • CHRISTIAN OMAR CRUZ
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Commerce, Dept of (DOC)
  • Health & Human Services, Dept of (HHS)
Activity 4
Pharmacy

Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 2841 FAST Generics Act, Dormant Therapies Act, H.R. 3513 Prescription Drug Affordability Act, S. 2023 Prescription Drug Affordability Act

Lobbyists (5)
  • MR. CHRISTOPHER DAVIS
  • CHRISTINE SIMMON
  • MELISSA SCHULMAN
  • HEIDI WILSON
  • CHRISTIAN OMAR CRUZ
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Commerce, Dept of (DOC)
  • Health & Human Services, Dept of (HHS)
Activity 5
Trade (domestic/foreign)

H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act, S. 995 Bipartisan Congressional Trade Priorities and Accountability Act, Trans-Pacific Partnership

Lobbyists (2)
  • MR. CHRISTOPHER DAVIS
  • MELISSA SCHULMAN
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Commerce, Dept of (DOC)
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved November 4, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.